baber/WOPTO huggingface dataset:
Patent IE-41764-L (IE)
Title: Cyclopropane carboxylic acid derivatives.
IPC: C07C67/00
Filed: 1974-10-22
Abstract: 1465568 Racemic or optically active derivatives of cyclopropane carboxylic acid ROUSSEL UCLAF 22 Oct 1974 [22 Oct 1973] 45653/74 Headings C2C and C2P The invention relates to racemic or optically active derivatives of cyclopropane carboxylic acid of cis or trans structure of Formula I in which R represents either a R 1 group which is either hydrogen, or an alkali metal atom, or an alkyl radical containing from 1 to 6 carbon atoms, substituted if necessary, or a R 2 group which is either a benzyl radical, substituted, if necessary, by one or more substituents selected from an alkyl, an alkenyl, an alkadienyl, a methylenedioxy, a benzyl radical and a halogen atom, or a cyclohexene dicarboximide methyl radical having a double bond at any position in the hexagonal nucleus and, if necessary, substituted on the said hexagonal nucleus by one or more halogen atoms, one or more methyl radicals or one or more acetoxy radicals, or a radical of formula in which Y 1 and Y 2 , the same or different, represent hydrogen, an alkyl, alkenyl or alkadienyl radical and Y 3 represents hydrogen, an alkyl, alkenyl, alkadienyl, alkynyl, or aryl radical or a heterocyclic radical, all these radicals being capable, if necessary, of being substituted, or a 1-oxo 2-Z 3-methyl 2-cyclopentene 4-yl residue of formula in which Z represents an alkyl, alkenyl, alkynyl, aryl, aralkyl, cycloalkyl, or cycloalkenyl radical or a heterocyclic radical. The compounds have insecticidal properties. Compounds of the general Formula I in which R is H are prepared by reacting 2,2-dimethyl 3- formyl cyclopropane 1-carboxylic acid, the configuration of which at the 1- and 3-positions is the same as that desired in the product, with a phosphonate or phosphorane containing a 1- ethyl propane-2-one 1-yl chain in the presence of a strong base. Suitable phosphonates include, for example, O,O-dialkyl alpha-ethyl acetonyl phosphonate and a suitable phosphorane is, for example, an alpha-ethyl acetonyl triaryl phosphorane, e.g. alpha-ethyl acetonyl triphenyl phosphorane. Compounds of the general Formula I in which R is other than H or an alkali metal atom are prepared by reacting a compound of Formula I wherein R represents hydrogen or an alkali metal (or a functional derivative thereof) with a compound of formula XOH (or a functional derivative thereof) wherein X represents a group R 2 or an optionally substituted alkyl group. When R represents hydrogen then this acid may, if desired, be used in the form of, for example, its acid chloride, anhydride, mixed anhydride or a salt. The alcohol of formula XOH may, for example, be used in the form of a halide derivative of formula X-Hal or an alkali metal derivative. Alpha-ethyl-acetonyltriphenylphosphorane is prepared by reacting propyltriphenyl phosphonium iodide with ethyl thioacetate. Dipropyl alphaethyl acetonylphosphonate is produced by reacting tripropyl phosphonate and ethyl acetate.
[GB1465568A]
Patent IE-45846-L (IE)
Title: Slurry explosive composition
IPC: C06B47/14
Filed: 1977-11-28
Abstract: 1536180 Explosive compositions IMPERIAL CHEMICAL INDUSTRIES Ltd 21 Nov 1977 [29 Dec 1976] 54238/76 Heading C1D A slurry explosive composition comprises an inorganic oxidizing salt, a liquid solvent, disperser or carrier for the salt, and a liquid 3-8 carbon atom aliphatic mononitrate, which acts as a sensitizing fuel and is emulsified with the liquid solvent, disperser or carrier. The liquid mononitrate may be n-propyl nitrate, isopropyl nitrate, amyl nitrate, hexyl nitrate, or octyl nitrate. Suitable solvents, dispersers or carriers are water, diethylene glycol, formamide, dimethyl formamide, dimethyl sulphoxide, or a liquid mixture containing ammonium acetate or formate, methylamine nitrate, or ethylene diamine dinitrate. Oxidizing salts referred to are nitrates and perchlorates of ammonium, Na, K, Ba, Mg, and Ca; aluminium nitrate is included in one composition. A number of emulsifying agents of the oil-in-water or water-in-oil type are specified; these include polyalkylene oxide condensates with alcohols, phenols, resins, or amines, longchain amine oxides, and alkyd condensates of polyethylene glycol with carboxylic acids. Aluminium or magnesium powder may be included as an additional fuel. Agents to control the emulsion droplet size, emulsion stabilizers, thickening agents for the aqueous or aliphatic nitrate phase, and cross-linking agents may also be added; many specific examples of these additives are given. The composition may be aerated by using a foaming surfactant or by including a chemical gassing agent; alternatively hollow microspheres may be included. Specifications 1,180,677 and 1,229,736 are referred to.
[GB1536180A]
Patent IE-883843-L (IE)
Title: Granules of cimetidine useful in preparing tablets thereof
IPC: A61K31/415
Filed: 1988-12-22
Abstract: The present invention provides a pharmaceutical granule composition comprising cimetidine and, as a granulating agent and taste-masking agent, an ester of a polyhydroxy compound, and where desired a palatable pharmaceutically acceptable emulsifier. Particular esters are glycerol esters. The granules of the present invention can be used in the preparation of chewable tablets which have good palatability and bioavailability.
Patent NO-803862-L (NO)
Inventor: STAEHLE HELMUT
IPC: C07D409/12
Filed: 1980-12-18
Abstract: Compounds of the formula   <IMAGE>   wherein R is bromine or trifluoromethyl, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs, analgesics and locomotion inhibitors.
Patent NO-810699-L (NO)
Inventor: KLEISS JOACHIM
IPC: B32B15/08
Filed: 1981-03-02
Abstract: 1. A profile for windows or doors, which consists of an extruded aluminium hollow profile with a plastics coating of polyurethane foam, in which a primer, as adhesive base for the polyurethane foam, is provided between the surface of the aluminium profile and the plastics foam, characterized in that the primer is a resin/pigment/acid compound, in which the resin is phenolic resin and/or polyvinylbutyral, the pigment is a zinc compound and the acid is phosphoric acid.
Patent NO-821663-L (NO)
Inventor: HEGLER WILHELM
IPC: B29C49/04
Filed: 1982-05-19
Abstract: An apparatus for the production of plastic pipes with transverse grooves comprising half shells each having a mold recess which are arranged on a machine bed driven in a cycle. The half shells are assembled in pairs in a molding path to form a complete mold, the injection head of an extruder being arranged at the beginning of the molding path. Furthermore, the half shells are provided with vacuum channels, each vacuum channel being connected to a respective mold recess. The vacuum channels are joined into vacuum connections formed in the machine bed, and the half shells are provided with cooling channels which join into cooling water inlets and outlets in the machine bed. In order to ensure an exact setting of the half shells during the molding operation, the cooling channels, on the one hand, and the vacuum channels on the other hand, in a given half shell are completely separated from each other.
Patent NO-833940-L (NO)
Inventor: COUSIN STEPHANE
IPC: E04D3/35
Filed: 1983-10-28
Abstract: This invention relates to a fibrous panel and to a process and apparatus for its manufacture, the panel includes a dense felt mat (2) of mineral fibres having on at least one of its main surfaces an impervious covering (3, 7) consisting of a reinforcing film (3) of mineral fibres impregnated with a binder, for example bitumen, and bonded to the felt (2) by the binder, and having, on the external surface, a separating agent (7) glued to the film (3) by the binder, the agent (7) being self welding in the heat. The panels according to this invention are advantageous for the insulation and weatherproofing of roofs, especially those with only a slight slope, in particular on account of their reliability in use as well as that of the impervious coverings for which they serve as support.
Patent NO-850691-L (NO)
Title: Boreroer.
Inventor: NARUM HENNING
IPC: E21B17/00
Filed: 1985-02-21
Abstract: Borerør for dannelse av en borestreng,særlig beregnet til avviksboring. For å oppnå liten heft mot veggen i det hull som bores omfatter borerøret et hovedsakelig skruelinjeformet rør (1) med et hode (2,3) på hver ende.
Patent NO-863877-L (NO)
Inventor: DINGERDISSEN JOHN JOSEPH
IPC: C12P21/04
Filed: 1986-09-29
Abstract: A novel subspecies of Kibdelosporangium aridum, subsp. largum (SK&F-AAD-609) produces AAD-216 antibiotics and AAD-609 antibiotics, the AAD-609 antibiotics differing from the AAD-216 antibiotics in presence of glucosamine in the glycolipid radical in place of amino glucuronic acid.
Patent NO-894571-L (NO)
Inventor: ANDREOLI PETER MICHAEL
IPC: C12R1/19
Filed: 1989-11-16
Abstract: Novel microbial host strains are provided which are transformed by a vector molecule comprising a DNA fragment encoding a lipolytic enzyme and a marker for selection, capable of producing active lipase. Said DNA fragment is preferably derived from a Pseudomonas species.
Patent NO-903579-L (NO)
Inventor: PAJONK MANFRED
IPC: G05B15/02
Filed: 1990-08-15
Abstract: The invention relates to a flexible automation system for variable industrial processes, for example for the processes on a production platform for oil or gas, comprising automation devices (a...z) preferably interlinked via bus structures (1), which are supplied with process variables (P1,2,3... Pn, n+1, n+x) in digital or analog form, the bus structures (1) exhibiting communication interfaces (a1...z1) for calling up the process variables (P1,2,3... Pn,n+1,n+x) from the automation devices (a...z) and a call-up signal in coded form being allocated to each process variable (P1,2,3... Pn, n+1, n+x). <IMAGE>
Patent NO-912671-L (NO)
Inventor: KLAVENESS JO
IPC: A61K49/04
Filed: 1991-07-08
Abstract: PCT No. PCT/EP90/00053 Sec. 371 Date May 20, 1991 Sec. 102(e) Date May 20, 1991 PCT Filed Jan. 8, 1990 PCT Pub. No. WO90/07491 PCT Pub. Date Jul. 12, 1990.Water insoluble iodinated esters of formula (I), in which R1 is a substituted or unsubstituted C1-20 aliphatic, C7-20 araliphatic or C6-20 aryl group or a C1-20 heterocyclic group having one or more hetero atoms selected from O, S and N; R2 is hydrogen or a substituted or unsubstituted C1-6 aliphatic, C6-10 aryl or C7-20 araliphatic group; and R3 is a group as defined above for R1, which may be the same as or different from R1, or R2 and R3 together represent a substituted or unsubstituted C1-4 alkylene group, the molecule containing at least one iodine atom and being metabolisable to products which are soluble in body fluids and are physiologically acceptable. The esters are useful in X-ray and ultrasound imaging, especially liver and spleen imaging.
Patent NO-915007-L (NO)
Title: Selvsentrerende skjoet for roerledninger
Inventor: POLDERVAART LEENDERT
IPC: F16L37/00
Filed: 1991-12-18
Abstract: "Hurtigkopling" eller skjøt for fluid- tett forbindelse av to skjøtdeler, hver med tetningselemenlter med flater innrettet for tetning, idet minst en flate har fleksible pakninger (19, 20). Skjøten har videre koplingselementer (13, 17) for sentrering, og låseelementer (26) for fastlåsing etter sammenføyning av skjøtens deler. For å forenkle koplingen og redusere kostnadene er en sammenføyningsdel i den ene del av skjøten utrustet med en avskrådd ende (25), mens den andre del av skjøten har en tilsvarende innvendig avskrådd del (14) som danner et sete. Et koplingshode som består av flere skjøter, f.eks. konsentrisk anordnet, er en videreføring.
Patent NO-924207-L (NO)
Inventor: MYERS ROBERT M
IPC: A61N1/30
Filed: 1992-11-02
Abstract: An electrically powered iontophoretic delivery device is provided. The device utilizes electrodes composed of a polymeric matrix containing about 5 to 40 vol % of a conductive filler which forms a conductive network through the matrix, and about 5 to 40 vol % of a chemical species which is able to undergo either oxidation or reduction during operation of the device. Preferably, the conductive filler is carbon or graphite fibers. For the anode electrode, the chemical species should be able to undergo oxidation and is preferably either silver or zinc. For the cathode electrode, the chemical species should be able to undergo reduction and is preferably silver chloride.
Patent NO-931184-L (NO)
Inventor: PIANI SILVANO
IPC: C08B37/10
Filed: 1993-03-30
Abstract: The synthesis of new semi-synthetic glycosaminoglycans with heparin or heparan structure of  alpha -L-iduronic-2-O-sulfate acid modified in position 2 is described in which the sulfate group is, entirely or in part, substituted with a nucleophilic radical. These new semi-synthetic glycosaminoglycans of general formula IV <CHEM> have good pharmaceutical properties in that they may also be absorbed orally and have good anti-thrombotic activity accompanied by low risk of haemorrhage and reduced anti-coagulating activity.
Patent NO-933098-L (NO)
Inventor: ROENNBERG PETER
IPC: A61F5/453
Filed: 1993-08-31
Abstract: PCT No. PCT/SE92/00124 Sec. 371 Date Aug. 19, 1993 Sec. 102(e) Date Aug. 19, 1993 PCT Filed Feb. 28, 1992 PCT Pub. No. WO92/15269 PCT Pub. Date Sep. 17, 1992An insert intended to be worn by a male incontinent and which, in use, is worn around the wearer's genitals, within an absorbent article, such as a diaper or an incontinence guard. The insert has a basin-like configuration and includes at least one opening (12) which enables liquid to flow through the insert, and elastic devices (4, 5) are disposed in the edge parts (6, 7) of the insert, such that, in use, the insert will retain its basin-like configuration and be held securely around the wearer's genitals.
Patent NO-933130-L (NO)
Inventor: NAMEN FREDERICK TJADO VAN
IPC: H02K33/06
Filed: 1993-09-02
Abstract: An electromagnetic actuator is disclosed which is especially suitable for active vibration control applications. The actuator may be either of the moving coil or moving magnet type so that a moving element undergoes reciprocal motion in response to an electrical input signal. The invention allows the force of the moving element to be linearly related to the amplitude and direction of the input current with a high degree of efficiency. In one embodiment, the moving element is decoupled from any mechanical load so as to produce reaction forces which may be used to cancel vibrational forces.
Patent NO-942361-L (NO)
Title: Fremgangsmåte og anordning for fremtilling av höyrent nitrogen
Inventor: SWEENEY PAUL A
IPC: F25J3/04
Filed: 1994-06-21
Abstract: Det er beskrevet en fremgangsmåte og apparat for fremstilling av et høyrent nitrogendampprodukt fra rektifisering av luft i høy-og lavtrykkskolonner (24, 26), operativt forbundet til hverandre ved en kondensa-tor/koker. Høytrykkskolonnen (24) innbefatter en tilstrekkelig antall teoretiske trinn til å danne en høyren nitrogendamp som deretter kondenseres 1 kondensatoren/kokeren og virker til delvis å kondensere en nitrogendamptoppstrøm med lavere renhet dannet i lavtrykkskolonnen (26) via indirekte varmeveksling. Den kondenserte høyrene nitrogendampen blir i det minste delvis fordampet og anvendes som en produkt-strøm. Siden det ikke er noen direkte varmeveksling med det høyrene nitrogenet dannet i høytrykkskolonnen (24) og nitrogendampen med lavere renhet dannet i lavtrykkskolonnen (26), kan lavtrykkskolonnen (26) innbefatte færre teoretiske trinn og kan derfor bygges rimligere enn tilsvarende kjente luftseparasjonsanlegg.
Patent NO-943230-L (NO)
Title: Naftoksaziner
Inventor: NOZULAK JOACHIM
IPC: C07D265/34
Filed: 1994-09-01
Abstract: Forbindelser med formel I hvor R! er (C1.4)alkyl, '(C3_6)alkenyl, hvorved dobbeltbindingen ikke er i a-stilling til nitrogenatomet, eller (C3_7)cyklo- alkyl(C1.2)alkyl, R2 er (C1.4)alkoksy, (C2.6) alkenyloksy eller (C3_7)cykloalkyl (Cj^.jjalkoksy, og R3 er (C^Jalkylkarbonyl, (C1.4)alkyl, a-hydroksy(C1.4)alkyl, (C2.5)alkenyl, (C^.^) - alkoksy(C1.4)alkyl eller (C3.7) cykloalkyl. Forbindelsene utviser serotonin-lD reseptoragonistaktivitet.
Patent NO-944145-L (NO)
Inventor: HAIKALA HEIMO OLAVI
IPC: C07D237/04
Filed: 1994-10-31
Abstract: PCT No. PCT/FI93/00191 Sec. 371 Date Nov. 22, 1994 Sec. 102(e) Date Nov. 22, 1994 PCT Filed May 5, 1993 PCT Pub. No. WO93/21921 PCT Pub. Date Nov. 11, 1993.A method for preventing or treating myocardial ischemia in a mammalian organism is disclosed. The compound [[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile or its enantiomer or a pharmaceutically acceptable salt there is administered to a mammalian organism in need of such prevention or treatment. The compound may be administered in its racemic form or in a form which is substantially free of the (+)-enantiomer or substantially free of the (-)-enantiomer.
Patent NO-952947-L (NO)
Title: Videodensitometer med bestemmelse av fargesammensetning
Inventor: ZIEGLER DANIEL M
IPC: H04N7/18
Filed: 1995-07-25
Abstract: Måling av integrerte denslteter for gråskala eller fargesammensetning ved uregelmessig formede områder på et prøvestykke (52) foregår ved bruk av et videokamera (54) for å frembringe et analogt vldeoblldeslgnal som representerer den optiske styrke på lys knyttet til prøvestykket. En modifisert billig høyhastlghets vldeodlgltallserer (58) omformer vldeblldeslgnalet til et digitalt format som et Interaktivt dataprogram (64) omformet til digitale optiske densltetsverdler som benyttes til å bestemme netto Integrert densitet for hvert uregelmessig formet område på prøvestykket.
Patent NO-953420-L (NO)
Title: Oksa- eller tiaalifatiske broinneholdende chinoksalin-2-dioner
Inventor: MORETTI ROBERT
IPC: A61P25/20
Filed: 1995-08-31
Abstract: Oksa- og tiaallfatlske broinneholdende chlnoksalln-2,3- dioner med generell formel I (D. der A1 representerer laverealkyllden eller en gruppe med formel >CH-A4-R4 (la), A2 er lavere alkyllden eller en gruppe med formelene >CH-A4-R4 (IA), >C-0 (lb) eller >CH(OH)-A5-R4 (Ic), A3 betyr oksy, eventuelt oksydert tlo eller en gruppe >C(-0) (lb), A4 står for laverealkylen, A5 representerer laverealkylen eller en dlrekteblndlng, n står for O eller l, R! og R£ betyr uavhengig av hverandre hydrogen, eventuelt med laverealkyl og/eller laverealkanoyl substituert amlno, nltro, laverealkanoyl, eventuelt foretret eller forestret hydroksy, eventuelt forestret eller amldert karboksy, cyano, eventuelt halogenert laverealkyl eller halogen, R3 betyr hydrogen eller hydroksy, og R4 representerer hydrogen, cyano, eventuelt forestret eller amldert karboksy, eventuelt forestret fosfono eller 5-tetrazolyl,
Patent NO-953782-L (NO)
Inventor: SAITO YUTAKA
IPC: A24F47/00
Filed: 1995-09-25
Abstract: A smoking article (10) contains a flavor component retainer obtained by heating and gelling a mixture of a flavor component and a non-gelled glucan and containing heat-irreversibly gelled glucan, and a flavor generation material containing the flavor component retained by this retainer as a combustion smoking raw material (12). Since the flavor component is firmly fixed and retained inside a three-dimensional network structure of gelled glucan, preservability and emission durability of the flavor component can be improved. <MATH>
Patent NO-974435-L (NO)
Inventor: FARNHOLTZ ROGER
IPC: A61B17/12
Filed: 1997-09-25
Abstract: This is an assembly for controllably delivering vaso-occlusive devices to a selected site within the vasculature or other lumen of human body by the use of a catheter. In particular, the device includes a holding member which is at least generally tubular and has an opening through the tubular wall. The vaso-occlusive device to be delivered has on one end a mating member which may be at least partially pressed into the opening in the wall of the holding member. The mating member attached to the vaso-occlusive member is held in the opening with an interference wire. The interference wire is axially movable within the holding member and has a diameter sufficient to hold the mating member within the wall opening. Upon proximal movement of the interference wire, the mating member becomes free to leave the holding member. The interference wire may be tapered or not. The vaso-occlusive member may be a helically wound coil or a braid or other appropriate form. <IMAGE>
Patent NO-975202-L (NO)
Title: BµrehÕndtak
Inventor: SLOMSKI EDWARD J
IPC: B65D71/50
Filed: 1997-11-12
Abstract: Bærer og en fremgangsmåte for å utforme denne, for å bære et antall beholdere (22), spesielt flasker og kanner, er utformet av en håndtaksdel (26) som har et antall hemper (46) langs en kant, og en plan beholderkontaktdel (24) som har et antall åpninger (28) igjennom, og som er anordnet i rekker. Hver åpning bærer en av beholderne. Håndtaksdelen og beholderdelen er utformet separat, og kan lages av ulike plastmaterialer. For å danne den ferdige bærer blir hempene smeltet eller sveiset til beholderkontaktdelen mellom rekkene av åpninger. I en første utførelse er beholderkontaktdelen utstyrt med et antall slisser (38) mellom rekkene av åpninger. Hempene på håndtaksdelen blir ført gjennom slissene og smeltet eller sveiset på undersiden av beholderkontaktdelen for å danne en sterk, rivebestandig sveiseskjøt. I en annen utførelse er slissene eliminert, og hempene smeltet eller sveiset direkte på oversiden av beholderkontaktdelen.
Patent NO-993219-L (NO)
Title: Termoplastisk sammensetning
Inventor: TSAI FU-JYA
IPC: C08K5/092
Filed: 1999-06-29
Abstract: Det er fremlagt en termoplastisk sammensetning som innbefatter en ureagert blanding av en alifatisk polyesterpolymer og en multikarboksylsyre. Et eksempel på en slik termoplastisk sammensetning er en blanding av poly(melkesyre) og adipinsyre. Den termoplastiske sammensetningen kan ekstruderes til fibre og kan formes til nonwoven strukturer som kan anvendes i et engangs absorbentprodukt ment for absorpsjon av fluider slik som kroppsfluider.
Patent NO-996447-L (NO)
Inventor: OSHLACK BENJAMIN
IPC: A61K47/44
Filed: 1999-12-23
Abstract: (A) Controlled release oxycodone formulation for oral admin. to human patients, comprises (i) 10-40mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-60 ng/ml from a mean of 2-4.5 hrs.. After admin., and a mean min. plasma conc. of 3-30 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady state conditions. (ii) 10-160 mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin., and a mean min. plasma conc. from 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions. (B) Also claimed is a solid controlled release oral dosage form comprising (i) oxycodone or its salt in amt. of 10-160 mg; a controlled release matrix selected from hydrophilic hydrophobic polymers, digestible opt. substd. 8-50C hydrocarbons, and/or polyalkylene glycols; and a diluent; wherein the compsn. provides a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin, and mean min. plasma conc. of 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions; or (ii) an analgesically effective amt. of spheroids comprising oxycodone or its salt and either a spheronising agent or an acrylic polymer or copolymer, such that the total dosage of oxycodone in the dosage form is 10-160 mg; a film coating which controls the release of the oxycodone or its salt at a controlled rate in an aq. medium, wherein the compsn. provides an in vitro dissolution rate of the dosage form.
Patent SE-0002255-L (SE)
Inventor: ARVIDSSON DESIREE
IPC: A01J9/00
Filed: 2000-06-16
Abstract: The present invention relates to a method of milking an animal comprising the following steps: drawing milk from the teats of said animal, separating the milk depending on the time of day or night, and collecting the separated milk. Preferably, the animal is identified and the milk is separated also depending on the identification of said animal. Advantageously, the separation of the milk depending on the time of day or night is dependent upon the identification of the animal.